Mircera 50 Mcg Injection
4800 INR/Piece
Product Details:
- Pacakaging (Quantity Per Box) 1
- Origin of Medicine Swiss
- Salt Composition Methoxy Polyethylene Glycol-Epoetin Beta
- Indication Treatment of anemia associated with chronic kidney disease
- Dosage Form Injection
- Drug Type Biological
- Ingredients Methoxy Polyethylene Glycol-Epoetin Beta
- Click to View more
X
Mircera 50 Mcg Injection Price And Quantity
- 1 Piece
- 4800 INR/Piece
Mircera 50 Mcg Injection Product Specifications
- Methoxy Polyethylene Glycol-Epoetin Beta
- Treatment of anemia associated with chronic kidney disease
- Doctor
- Injection
- 1 prefilled syringe
- Erythropoiesis-stimulating agent
- Adults
- Biological
- Other
- Keep dry & cool place
- Swiss
- 1
- As per physician
- 50 mcg
- Methoxy Polyethylene Glycol-Epoetin Beta
Product Description
Product Details:
- Usage/Application : Personal
- Brand : Mircera 50 mg injection
- Composition : Methoxy polyethylene glycol-epoetin beta (50mcg)
- Packaging Type : pfs
- Packaging Size : pfs
- Dose/Strength : 50 mg
Highly Effective Anemia Treatment
Mircera 50 Mcg Injection effectively stimulates erythropoiesis, leading to increased red blood cell production in patients suffering from anemia due to chronic kidney disease. Its long-acting formulation ensures prolonged activity, reducing the frequency of dosing compared to traditional therapies. Administered through subcutaneous or intravenous routes, it offers flexibility for both home and clinical settings under proper medical guidance.
Safe and Convenient Delivery System
The product comes in a single-use prefilled syringe, ensuring precise dosing and minimizing contamination risk. Manufactured in Switzerland and distributed through authorized dealers and healthcare professionals in India, Mircera must be stored in a cool, dry place and used only under medical supervision. Meticulous packaging and stringent quality standards further guarantee patient safety.
FAQ's of Mircera 50 Mcg Injection:
Q: How should Mircera 50 Mcg Injection be administered?
A: Mircera 50 Mcg Injection should be given either subcutaneously or intravenously by a healthcare professional as per your doctor's specific instructions. Self-administration is not recommended unless properly trained by your healthcare provider.Q: What is the purpose of using Mircera 50 Mcg Injection?
A: Mircera is used to treat anemia associated with chronic kidney disease in adults by stimulating the production of red blood cells, thereby improving symptoms such as fatigue and shortness of breath.Q: When is Mircera contraindicated for use?
A: Mircera should not be used in individuals with uncontrolled hypertension or those who have had hypersensitivity reactions to Methoxy Polyethylene Glycol-Epoetin Beta or any other ingredient in the formulation.Q: Where should Mircera 50 Mcg Injection be stored to maintain its efficacy?
A: Mircera should be kept in a dry and cool place, away from direct sunlight, and out of reach of children. Avoid freezing the injection to retain its effectiveness and safety.Q: What process should be followed if a dose is missed?
A: If you miss a scheduled dose of Mircera, contact your healthcare provider for instructions. Do not administer a double dose or adjust the schedule without professional guidance.Q: What are the common side effects of Mircera 50 Mcg Injection?
A: Frequent side effects include hypertension, headache, and reactions at the injection site such as redness or swelling. Consult your doctor if you experience these or any other unusual symptoms.Q: What benefits does Mircera 50 Mcg Injection offer over other anemia treatments?
A: Mircera's extended duration of action means fewer injections are needed, enhancing patient comfort and adherence to treatment, while maintaining effective anemia management under medical supervision.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anaemia Medicine' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
